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Abstract
Purpose: We present the unusual occurrence of two distinct neoplasms in a 42-year-old woman
with an operated pituitary adenoma 18 years ago.
Methods: Clinical history, magnetic resonance imaging studies and histopathological findings were
utilized for our diagnostic considerations.
Results: Concomitant presence of a cerebellar medulloblastoma secondary disseminated within
the spinal canal and a pituitary macroadenoma, was identified.
Conclusion: To the best of our knowledge, this is the first reported case in which these two
neoplasms are simultaneously occurred in the same individual. A short review of the literature is
performed.
Introduction
Medulloblastomas are posterior fossa tumors preferen-
tially manifested in children less than 15 years and rarely
occurring in adults [1]. These tumors, belonging to the
family of central primitive neuroectodermal tumors
(cPNETs), are highly malignant entities with an inherent
tendency to metastasize via the cerebrospinal fluid (CSF)
pathway [1]. This phemomenon occurs in up to 30% of
all patients at the time of initial diagnosis [1,2] with some
researchers believing that all patients have already meta-
static disease in the spinal cord at the time of first detec-
tion of the tumor [2].
Pituitary tumors constitute about 10–15% of all intracra-
nial tumors [3]. Pituitary adenomas, in particular, belong
to the family of pituitary tumors and they are defined as
benign neoplasms located in the sellar turcica [3]. The
treatment, consisting of surgery, irradiation and pharma-
ceutical therapy or a combination of them, targets at the
control of tumor cell proliferation and the reduction of
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plasms) [4,5]. These tumors, however, carry a risk for
recurrence even many years after the initial treatment
[3,5].
Simultaneous occurrence of two different tumors in a
patient, including cases which concern the central nervous
system (CNS), has been previously described in the litera-
ture [6-9]. This rare phenomenon is mainly associated
with cases in which two concurrent but histologically
unrelated neoplastic elements have collided with each
other, in the same organ [8].
In this context, we report the case of a 42-year-old woman
suffering simultaneously from a cerebellar medulloblast-
oma, secondary disseminated within the spinal canal, and
a pituitary macroadenoma. The patient had been operated
18 years before due to a pituitary adenoma. Taking into
account the published data, for the first time a medullob-
lastoma coexists with a pituitary tumor.
Case presentation
A 42-year-old woman was admitted to the Hellenic Red
Cross Hospital with diminished function of her right leg
as well as sensory disturbances of one week duration.
Neurological examination revealed paresis of the right leg,
and increased tendinous reflexes in both legs. The abdom-
inal reflexes were all abrogated. During hospitalization
the patient showed deterioration of neurological symp-
toms with severe paresis of both legs as well as urinary
incontinence.
The specific details of patient's history were as follows:
Occupation: housewife; Ethnicity: Ukranian; Weight: 65
Kgr; Height: 180 cm; Medical history: previous surgery 18
years ago due to a pituitary adenoma-no data available
regarding the completeness of the resection and the
administration or not of irradiation therapy; Family his-
tory: unremarkable; Pregnancies: no; Smoking: no; Drink-
ing alcohol: no; Current medications: no.
Magnetic resonance imaging (MRI) of the brain demon-
strated an inhomogeneously contrast-enhancing, multi-
lobulated tumor of the posterior cranial fossa, measuring
3 × 3 × 2,3 cm [Fig. 1]. The mass was hyperintense in T2-
weighted images and hypointense in T1-weighted images
relative to cortical grey matter. The tumor had an intimate
liaison with the cerebellum surrounding the upper level of
vermis and cerebellar hemispheres and projecting into the
roof of the fourth ventricle. The mass caused a compres-
sive effect into the posterior surface of the brainstem's
peduncles, displacing the aqueduct of Sylvious. It was not
observed supratentorial extension of the lesion, the epiph-
ysis was normal, the ventricles were not dilated and it was
not noted any subdural or epidural blood collection.
The imaging studies, additionally, showed a recurrent
macroadenoma of the pituitary gland with greatest diam-
eter 2,8 cm [Fig. 1]. The mass caused expansion of the
sellar turcica, occupying the suprasellar cisterns, mainly
on the right. Furthermore, the tumor compressed the opti-
cal chiasm and the ipsilateral optical fibers, especially on
the right. Compressive results were also observed on the
third ventricle as well as on the hypothalamus. The mass
was characterized from heterogeneous, intense uptake of
the contrast material and was closely related to carotid
siphons, mostly on the right. Biochemical tests, however,
did not show any abnormality regarding the levels of the
pituitary hormones.
MRI of the spinal cord, also, showed multiple intradural-
extramedullary masses with obstructive effects especially
in the upper level of thoracic spinal cord as well as small-
size tumors in the entire length of the spinal cord. More
specifically, the contrast-enhancing masses of the upper
thoracic cord had greatest diameter from <10 mm to 3,2
cm and were isointense in T1 and T2-weighted images rel-
ative to spinal cord [Fig. 2]. The biggest tumor was accom-
panied by small satellite lesions and encased the spinal
nerve roots displacing some of them laterally. Surgical
intervention took place in order to decompress the tho-
racic cord in the level of T3–T7. Nevertheless, the opera-
tion had only a debulking result, since the tumor was
intimately connected with a large number of nerve roots.
A non-circumscribed, soft, friable, partly necrotic mass,
measuring 3 × 1,5 × 0,5 cm, from the biggest mass in the
thoracic spinal cord, was excised, fixed in formalin 10%
and embedded in paraffin. The histological and immuno-
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lyzed using the conventional stain with hematoxylin/
eosin and the Bond-maX system (Vision BioSystems Ltd,
Australia) according to the manufacturer's instructions.
The Primo Star upright microscope and the Axio Cam IC
camera (Carl Zeiss MicroImaging Inc, North America)
were also utilized for assessing and capturing of images.
Specifically, a small cell malignant tumor with ill-defined
rosettes was identified [Fig. 3]. Immunohistochemical
analysis demonstrated that the neoplastic cells were dif-
fusely positive for NCAM and Vimentin and focally for
Synaptophysin, NSE and C-Kit. GFAP staining was only
positive in reactive astrocytes. MCK, S-100, LCA, CD99,
Desmin, Chromogranin-A and Myo-1 were all negative.
The Ki67 index was >50%.
These histopathological results along with the MRI find-
ings of the brain's examination were consistent with a
diagnosis of a central PNET (medulloblastoma) of the cer-
ebellum with secondary dissemination through the CSF.
The mass of the cerebellum was not excised as it did not
demonstrate serious compressive results and it was neces-
sary to avoid any further aggravation of the general medi-
cal status of the patient. The patient received CNS
irradiation in another medical center but chemotherapy
was not administered since the patient refused any further
medical treatment. Unfortunately, the patient died one
year after the initial diagnosis.
Discussion
We described the case of a medulloblastoma primary
localized in the cerebellum of a 42-year-old woman with
secondary dissemination through the CSF pathway. How-
ever, our case was further complicated as it was detected a
mass in the sellar region with an imaging appearance fully
consistent with a pituitary macroadenoma. To the best of
our knowledge, this is the first report in the literature of a
medulloblastoma coexisting with a pituitary tumor, in the
same individual.
Regarding differential diagnosis, a pituitary carcinoma,
developed in the ground of the adenoma and exhibited
metastatic lesions in the CNS, including the cerebellum as
well as the spinal cord, was the main entity under consid-
eration. The histological features, however, as well as the
immunohistochemical profile (chromogranin A negative
and vimentin positive) of the lesion of the spinal cord
excluded this diagnosis. Furthermore, there was not noted
any evidence of metastatic disease elsewhere, a finding
usually observed in pituitary carcinomas [3]. Thus,
according to the MRI findings and the clinical history, we
deduced that the pituitary tumor was a recurrent pituitary
adenoma, 18 years after the initial operation for the first
pituitary tumor.
As a matter of fact, the occurrence of two distinct tumors
within CNS has been previously described in the litera-
ture. Interestingly, Gironimi et al. in 1981 reported the
case of a primary Burkitt-type lymphoma of the CNS,
developed in an 11-year-old boy 6 months after extirpa-
tion of an astrocytoma, stressing the notion of collision
T1-weighted MRI: Tumors of the cervical and thoracic cord (singl  arrow)Figure 2
T1-weighted MRI: Tumors of the cervical and tho-
racic cord (single arrow). In addition, the tumors of 
the sellar turcica (double arrow) and cerebellum 
(three arrows) are depicted.
Hematoxylin/Eosin (×400 magnification): Surgically excised lesion f the th racic spinal cord: Solid, small e  malignant neoplasm with ill-defined rosettesFigure 3
Hematoxylin/Eosin (×400 magnification): Surgically 
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researchers, additionally, have been described the coexist-
ence of oligodendroglioma with anaplastic astrocytoma
[9], pleomorphic xanthoastrocytoma [7], metastatic
breast carcinoma [10] and juvenile pilocytic astrocytoma
[11], within CNS.
Furthermore, Curto et al. recently presented the concur-
rent presence of pituitary adenoma, intracranial meningi-
oma and cerebral aneurysm highlighting the suggestion
that growth hormone or other growth factors could play a
role in appearance or in growth of meningioma [12]. Pre-
viously, Cannavò et al. had reported the coexistence of an
eosinophilic pituitary adenoma and an endothelioma-
tous meningioma, in the sellar region [13].
Attempting to explain the emergence of the medulloblas-
toma in our patient, two hypotheses could be considered.
The first one is related to a possible histogenetic or clinical
(as far as a specific syndrome is concerned) interconnec-
tion between medulloblastomas or cPNETs and pituitary
adenomas. However, there is no bibliographical evidence
for this kind of association and thus the above mentioned
theory must be excluded.
On the other hand, according to the second assumption,
the medulloblastoma could be developed as a result of the
previous therapeutic manipulations for the pituitary
tumor. Specifically, the patient most probably received
irradiation for the initially presented pituitary adenoma,
18 years ago. Therefore, given that the occurrence of a sec-
ond intracerebral neoplasm after craniospinal radiother-
apy is well recognized [14,15], it could be suggested that
this is the case regarding our patient.
Indeed, the estimated risk for the aforementioned second
tumors is thought to be as high as 1–2%, occurring with a
latency of 8–15 years [15]. A wide range of neoplasms can
result after irradiation for any kind of CNS malignancy
(including medulloblastomas), with a predominance of
astrocytomas, ependymomas, multiple meningiomas,
schwannomas as well as malignant gliomas and sarcomas
[14,15].
Conclusion
In summary, regardless of the various explanations which
can be given, we reported the peculiar concomitant pres-
ence of a disseminated medulloblastoma and a pituitary
macroadenoma. The former tumor most probably pro-
gressed in the context of a previous irradiation therapy for
the initial pituitary adenoma, 18 years ago.
The major reason for which we consider irradiation as the
most likely causative factor for the expansion of the new
tumor is that radiotherapy accounts for the growth of a
second tumor in many other instances [14]. It should be
also emphasized that there is no proof of histogenetic or
clinical association between pituitary adenoma and
medulloblastoma, so far. However, we cannot exclude the
possibility of a specific yet undescribed genomic imbal-
ance which is responsible for the simultaneous progres-
sion of these two tumors. Further studies in a molecular
level may elucidate this phenomenon.
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